May 30, 2024

News Masters

Your one-stop shop for all things trending

DCA: A New Hope for Cancer-Related Fatigue?

3 min read
Cancer-related fatigue (CRF) is a common and debilitating side effect of cancer and its treatments. A promising new treatment for CRF is a drug called dichloroacetate (DCA). DCA has been shown to be effective in reducing fatigue in mice with cancer. Clinical trials of DCA for the treatment of CRF are already underway in the USA. If these trials are successful, DCA could be available to cancer patients in the USA within a few years.
healthcare

healthcare

Cancer-related fatigue (CRF) is a common and debilitating side effect of cancer and its treatments. It can cause extreme tiredness, weakness, and difficulty concentrating. CRF can have a significant impact on a person’s quality of life, making it difficult to work, socialize, and enjoy everyday activities.

There is currently no cure for CRF, but there are a number of treatments that can help to manage the symptoms. These treatments include lifestyle changes, such as getting regular exercise and eating a healthy diet, as well as medications and other therapies.

However, these treatments are not always effective, and many people with CRF continue to experience significant fatigue. This is why researchers are eagerly searching for new and more effective treatments for CRF.

One promising new treatment is a drug called dichloroacetate (DCA). DCA is a metabolism-targeting drug that has been shown to be effective in reducing fatigue in mice with cancer. A recent study by researchers at Yale Cancer Center found that DCA also helped to alleviate CRF in mice, without interfering with cancer treatments.

The researchers found that DCA treatment significantly reduced oxidative stress in muscle tissue of tumor-bearing mice. Oxidative stress is thought to be a major contributor to CRF.

The researchers also found that DCA treatment helped to preserve physical function and motivation in mice with late-stage tumors.

The results of this study suggest that DCA could be a promising new treatment for CRF in humans. However, more research is needed to confirm these results and to determine the safety and efficacy of DCA in humans with CRF.

What does this mean for cancer patients in the USA?

If DCA is proven to be safe and effective in humans, it could represent a major breakthrough in the treatment of CRF. It could offer cancer patients a new way to manage their fatigue and improve their quality of life.

DCA is already approved by the FDA for the treatment of certain metabolic disorders. This means that it is already available and could be relatively quickly repurposed for the treatment of CRF.

Clinical trials of DCA for the treatment of CRF are already underway in the USA. If these trials are successful, DCA could be available to cancer patients in the USA within a few years.

What can cancer patients do now to manage their fatigue?

While there is no cure for CRF, there are a number of things that cancer patients can do to manage their fatigue. These include:

  • Getting regular exercise: Exercise has been shown to be one of the most effective ways to reduce fatigue in cancer patients. Aim for at least 30 minutes of moderate-intensity exercise most days of the week.
  • Eating a healthy diet: Eating a healthy diet can help to improve your overall health and well-being, and it can also help to reduce fatigue. Make sure to eat plenty of fruits, vegetables, and whole grains.
  • Getting enough sleep: Most adults need around 7-8 hours of sleep each night. Getting enough sleep can help to reduce fatigue and improve your overall energy levels.
  • Managing stress: Stress can worsen fatigue. Find healthy ways to manage stress, such as exercise, relaxation techniques, and spending time with loved ones.
  • Talking to your doctor: If you are struggling to manage your fatigue, talk to your doctor. They can help you to develop a personalized treatment plan and provide you with support.

Cancer-related fatigue is a common and debilitating side effect of cancer and its treatments. However, there is hope for new and more effective treatments. A promising new treatment is a drug called dichloroacetate (DCA). DCA has been shown to be effective in reducing fatigue in mice with cancer. Clinical trials of DCA for the treatment of CRF are already underway in the USA. If these trials are successful, DCA could be available to cancer patients in the USA within a few years.

In the meantime, there are a number of things that cancer patients can do to manage their fatigue, such as getting regular exercise, eating a healthy diet, getting enough sleep, managing stress, and talking to their doctor.
Source

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | Newsphere by AF themes.